Ekso Bionics Holdings (NASDAQ: EKSO) shares were trading higher Friday on continued strength after the company received FDA clearance to market its EksoNR robotic exoskeleton.Ekso Bionics Holdings designs, develops and sells exoskeleton technology used in health care and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks.All of the company's operations are in the United States.The EksoHealth segment, which generates the majority of revenue, designs, engineers, manufactures and sells exoskeletons for applications in the medical markets.Ekso Bionics shares were trading up 16.25% at $8.48 on Friday at the time of publication. The stock has a 52-week high of $20.10 and a 52-week low of $2.25.Courtesy photo. See more from Benzinga * Amazon Buys Autonomous Driving Startup Zoox For A Reported B * Germany's Wirecard Investigation Brings Economic, Regulatory Models...
One of Wall Street's darlings amid the novel coronavirus pandemic has been clinical-stage, DNA medicine company Inovio (NASDAQ:INO). In fact, since the pandemic emerged globally in February 2020, the INO stock price has climbed from $3 to as high as $33.Source: Ascannio / Shutterstock.com It's easy to see why Wall Street fell in love with INO stock.After all, Inovio is one the leaders when it comes to developing a Covid-19 vaccine. The financial implications of such a vaccine are enormous, considering this is a pandemic which has infected nearly 10 million people globally and shut down the global economy for months. Furthermore, the company should be able to leverage its Covid-19 spotlight to accelerate the development and eventual distribution of other vaccine candidates in its pipeline.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIn other words, Covid-19 was truly a game-changer for this small biotech company. Having said all that,...
Cloud software company Okta released its "Cost of Privacy Data Report," which revealed that 87% of Americans are worried that COVID-19 data collection could make their data less secure. Okta COO Frederic Kerrest joins Yahoo Zack Guzman to break down the details....
The stock market rally after the novel coronavirus selloff has been stellar. Besides expansionary monetary policies, strong fundamentals have triggered the rally for several stocks and industries. And in particular, tech stocks have been on fire.In fact, it's the big names in the technology sector that have continued to deliver strong numbers. Innovation-driven business growth holds immense potential for the long term.That's why I want to share four tech stocks that you should buy and hold in your portfolio for the long term. These tech stocks have strong fundamentals, robust cash flows and a strong growth outlook for the coming years.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Consumer Stocks to Buy to Ride the Post-Covid-19 Wave Buy these tech stocks now: * Apple (NASDAQ:AAPL) * Facebook (NASDAQ:FB) * Amazon (NASDAQ:AMZN) * Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) Tech Stocks to Buy: Apple (AAPL)Source: View Apart / Shutterstock.com After a...
Airlines were all but out-of-business during the COVID-19 lockdown. Even before the virus, airline stocks were dirt cheap. While they were declaring fat dividends and buying back shares with both hands, most still had price-to-earnings multiples near 10.Investors had seen this story before. Most airlines declared bankruptcy at one time or another in the 2000s. In March it seemed they might do so again.The CARES Act and the Federal Reserve's actions to increase the money supply changed the equation. Major airlines secured billions in direct aid and billions more in loans that may not be repaid. They then got billions more in loans from a market desperate for yield, and worked hard to cut costs, even skirting the edges of the act in their efforts.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe question for investors is less which airline stocks might survive, but which will come back fastest in...
(Bloomberg) -- Exxon Mobil Corp. is preparing to cut jobs in the U.S. as the oil giant focuses on a slimmed-down and more efficient organizational structure, according to people familiar with the matter.Between 5% and 10% of U.S.-based employees who are subject to performance evaluations could end up leaving this year after their assessments, said the people, who asked not to be identified because they weren’t authorized to speak publicly. The cuts are expected to be performance-based and not characterized as layoffs -- and not all workers are subject to such evaluations, which typically apply to white-collar jobs such as engineering, finance and project management.Exxon said in a statement there’s no specific target to reduce headcount. “We have a rigorous talent management process which routinely assesses employee performance,” the company said.Chief Executive Officer Darren Woods told Exxon’s annual shareholders meeting last month that while there are no layoffs planned, the company...
